Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CNTB

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Connect Biopharma Holdings Ltd

CNTB
Current price
1.72 USD -0.17 USD (-8.99%)
Last closed 1.62 USD
ISIN US2075231017
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 67 499 136 USD
Yield for 12 month +35.43 %
1Y
3Y
5Y
10Y
15Y
CNTB
21.11.2021 - 28.11.2021

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California. Address: 3580 CARMEL MOUNTAIN ROAD, San Diego, CA, United States, 92130

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.50 USD

P/E Ratio

Dividend Yield

Financials CNTB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+26 033 000 USD

Last Year

Current Quarter

Last Quarter

+1 912 082 USD

Current Year

+25 373 000 USD

Last Year

-988 000 USD

Current Quarter

Last Quarter

+1 728 554 USD
EBITDA -20 597 000 USD
Operating Margin TTM -81.69 %
Price to Earnings
Return On Assets TTM -12.47 %
PEG Ratio
Return On Equity TTM -18.66 %
Wall Street Target Price 6.50 USD
Revenue TTM 26 033 000 USD
Book Value 1.50 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 26 033 000 USD
Earnings per share -0.31 USD
Diluted Eps TTM -0.31 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -66.10 %

Stock Valuation CNTB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 0.77
Enterprise Value Revenue
Price Sales TTM 2.59
Enterprise Value EBITDA 0.19
Price Book MRQ 0.73

Technical Indicators CNTB

For 52 Weeks

0.51 USD 1.60 USD
50 Day MA 0.88 USD
Shares Short Prior Month 17 062
200 Day MA 0.98 USD
Short Ratio 0.21
Shares Short 28 427
Short Percent 0.050 %